WHO ICTRP trial
Individual Medication Effectiveness Tests (IMETs) to assess the efficacy of…
ACTRN12605000479606 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12605000479606 |
|---|---|
| Public title | Individual Medication Effectiveness Tests (IMETs) to assess the efficacy of gabapentin in individual patients with chronic neuropathic pain. |
| Scientific title | Individual Medication Effectiveness Tests (IMETs) to assess the efficacy of gabapentin in individual patients with chronic neuropathic pain. |
| Primary sponsor | University of Queensland |
| Secondary sponsors | Princess Alexandra Hospital, Brisbane;Port Kembla Hospital, NSW |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | Australia |
| Conditions | Neuropathic pain.; Neuropathic pain.;Neurological - Other neurological disorders |
| Interventions | This single patient (n of 1) IMET is a randomised, double-blind, cross-over comparison of gabapentin and placebo within an individual patient. We will do an initial open label trial to see if gabapentin is effective, and for dose finding… |
| Registration date | Sep 23, 2005 |
| Target size | 150 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: